stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
무료 - Play StoreApp Store
설치하다설치하다
logo
Dyne Therapeutics IncDYN
$18.054.34%0.75
시간 외 거래: 18.050.00 0.00%

Dyne Therapeutics Inc (DYN)

Date: 2026-11-03 16:00O: 17.53H: 18.15L: 17.31C: 18.05Vol: 2.810M
전일 마감가:
$17.30
열려 있는:
$17.53
하루 거래량:
2,810,077
상대 거래량:
1.31
시가총액:
$3.37B
수익:
-
순이익/손실:
-$451.71M
주가수익비율:
-
EPS:
-$3.23
순현금흐름:
-$462.19M
1W 성능:
+6.55%
1M 성능:
+18.75%
6M 성능:
+3.80%
1Y 성능:
-25.13%
1일 변동 폭
$17.31$18.15
1주일 범위
$16.11$18.15
52주 변동 폭
$14.00$27.31

Dyne Therapeutics Inc 주식 (DYN) 회사 개요

명칭
Dyne Therapeutics Inc
전화
(781) 786-8230
주소
1560 TRAPELO ROAD, WALTHAM, USA
직원
258
X
-
다음 수익 날짜
2026-11-04
최신 SEC 제출 서류
SEC
X에서 DYN에 대한 토론
X

 

시가총액

 

매출

 

순이익

 

현금흐름

 

주당 순 이익

 

Dyne Therapeutics Inc 주식(DYN) 업그레이드 및 다운그레이드

날짜액션분석자등급 변경
2026-10-28다운그레이드OppenheimerOutperform → Perform
2026-09-09다운그레이드JP MorganNeutral → Underweight
2026-07-23개시Cantor FitzgeraldOverweight
2026-06-26개시TD CowenBuy

Dyne Therapeutics Inc (DYN) 재무 분석

기간추세FY 2025FY 2024FY 2023FY 2022FY 2021
기간 종료일2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.000.000.00
Research and development USD (M)398.33281.41210.76142.76121.31
Operating expenses USD (M)468.18343.89242.16170.96150.03
Operating income USD (M)-468.18-343.89-242.16-170.96-150.03
Income before tax USD (M)---235.94-168.10-149.29
Income tax expense USD (M)0.00----
Net income USD (M)-446.21-317.42-235.94-168.10-149.29
Basic EPS USD/shares-3.47-3.37-3.95-3.23-
Diluted EPS USD/shares-3.47-3.37-3.95-3.23-

Dyne Therapeutics Inc 주식 (DYN) 내부자 거래

  • Posner Brian SOct 02 '26
    Director
    거래
    Buy
    비용
    $16.00
    #주식
    2,500
    가치 ($)
    40,000
    #주식 총계
    27,000
  • Cox JohnSep 08 '26
    Officer
    거래
    Proposed Sale
    비용
    $18.88
    #주식
    5,658
    가치 ($)
    106,844
    #주식 총계
    0
  • Chief Commercial Officer
    거래
    Sale
    비용
    $18.88
    #주식
    185
    가치 ($)
    3,493
    #주식 총계
    152,897
  • Kerr DouglasSep 08 '26
    Officer
    거래
    Proposed Sale
    비용
    $18.89
    #주식
    35
    가치 ($)
    661
    #주식 총계
    0
  • Kerr DouglasSep 08 '26
    Chief Medical Officer
    거래
    Sale
    비용
    $18.88
    #주식
    1,290
    가치 ($)
    24,355
    #주식 총계
    162,564
  • Cox JohnSep 08 '26
    CEO & President
    거래
    Sale
    비용
    $18.88
    #주식
    5,658
    가치 ($)
    106,823
    #주식 총계
    357,507
  • Kerr DouglasSep 04 '26
    Officer
    거래
    Proposed Sale
    비용
    $24.35
    #주식
    5,000
    가치 ($)
    121,745
    #주식 총계
    0
  • Kerr DouglasSep 04 '26
    Chief Medical Officer
    거래
    Sale
    비용
    $24.35
    #주식
    3,745
    가치 ($)
    91,191
    #주식 총계
    163,854
  • Chief Commercial Officer
    거래
    Sale
    비용
    $24.35
    #주식
    900
    가치 ($)
    21,915
    #주식 총계
    153,082
  • Shareholder
    거래
    Proposed Sale
    비용
    $25.96
    #주식
    322,465
    가치 ($)
    8,371,191
    #주식 총계
    0
내부자 거래관계날짜거래비용#주식가치 ($)#주식 총계
Posner Brian SDirectorOct 02 '26Buy$16.002,50040,00027,000
Cox JohnOfficerSep 08 '26Proposed Sale$18.885,658106,8440
Friedl-Naderer JohannaChief Commercial OfficerSep 08 '26Sale$18.881853,493152,897
Kerr DouglasOfficerSep 08 '26Proposed Sale$18.89356610
Kerr DouglasChief Medical OfficerSep 08 '26Sale$18.881,29024,355162,564
Cox JohnCEO & PresidentSep 08 '26Sale$18.885,658106,823357,507
Kerr DouglasOfficerSep 04 '26Proposed Sale$24.355,000121,7450
Kerr DouglasChief Medical OfficerSep 04 '26Sale$24.353,74591,191163,854
Friedl-Naderer JohannaChief Commercial OfficerSep 04 '26Sale$24.3590021,915153,082
Atlas Venture Opportunity FundShareholderAug 14 '26Proposed Sale$25.96322,4658,371,1910

Dyne Therapeutics Inc 주식(DYN)의 최신 뉴스

Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 06, 2026
Oct 06, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 19, 2026
Sep 19, 2026
Sep 19, 2026
Sep 19, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026

DYN와(과) 유사한 종목